Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: Phenotype and genotype analysis

British Journal of Haematology

Volumn 122, Issue 2, 2003, Pages 326-332

  Carter, Kymberley ^a   Bowen, Derrick J ^a   McCune, C Anne ^a   Worwood, Mark ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Haemochromatosis; Haptoglobin; Iron

Indexed keywords

FERRITIN; HAPTOGLOBIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ADULT; ARTICLE; BLOOD DONOR; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON METABOLISM; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FERRITINS; GENOTYPE; HAPTOGLOBINS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LIVER; MALE; MEMBRANE PROTEINS; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; TRANSFERRIN;

EID: 0038824897     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04436.x     Document Type: Article

References (37)

1. Adams, P.C., Kertesz, A.E., Mclaren, C.E., Bamford, A. & Chakrabarti, S. (2000) Population screening for haemochromatosis: a comparison of unbound iron binding capacity, transferrin saturation and C282Y genotyping in 5211 voluntary blood donors. Hepatology, 31, 1160-1164.
2. Asberg, A., Hveem, K., Thorstensen, K., Ellekjaer, E., Kannelonning, K., Fjosne, U., Halvorsen, T.B., Smethurst, H.B.G., Sagen, E. & Bjerve, K.S. (2001) Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scandinavian Journal of Gastroenterology, 36, 1108-1115.
3. Beutler, E., Gelbart, T. & Lee, P. (2002a) Haptoglobin polymorphism and iron homeostasis. Clinical Chemistry, 48, 2232-2235.
4. Beutler, E., Felitti, V.J., Koziol, J.A., Ho, N.J. & Gelbart, T. (2002b) Penetrance of 845G > A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet, 359, 211-218.
5. Bowman, B.H. & Yang, F. (1987) DNA sequencing and chromosomal locations of human plasma protein genes. In: The Plasma Proteins V: Structure, Function and Genetic Control (ed. by F.W. Putman), pp. 1-48. Academic Press, Orlando, FL.
6. Burke, W., Thompson, E., Khoury, M.J., Mcdonnell, S.M., Press, N., Adams, P.C., Barton, J.C., Beutler, E., Brittenham, G., Buchanan, A., Clayton, E.W., Cogswell, M.E., Meslin, E.M., Motulsky, A.G., Powell, L.W., Sigal, E., Wilfond, B.S. & Collins, F.S. (1998) Hereditary hemochromatosis: gene discovery and its implications for population-based screening. Journal of the American Medical Association, 280, 172-178.
7. Deugnier, Y., Jouanolle, A.M., Chaperon, J., Moirand, R., Pithois, C., Meyer, J.F., Pouchard, M., Lafraise, B., Brigand, A., Caserio-Schoenemann, C., Mosser, J., Adams, P., Le Gall, J.Y. & David, V. (2002) Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. British Journal of Haematology, 118, 1170-1178.
8. Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., Dormishian, F., Domingo, R., Ellis, M.C., Fullan, A., Hinton, L.M., Jones, N.L., Kimmel, B.E., Kronmal, G.S., Lauer, P., Lee, V.K., Loeb, D.B., Mapa, F.A., McClelland, E., Meyer, N.C., Mintier, G.A., Moeller, N., Moore, T., Morikang, E., Prass, C.E., Quintana, L., Starnes, S.M., Schatzman, R.C., Brunke, K.J., Drayna, D.T., Risch, N.J., Bacon, B.R. & Wolff, R.K. (1996) A novel MHC class-1 like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399-408.
9. Fleming, R.E., Holden, C.C., Tomatsu, S., Waheed, A., Brunt, E.M., Britton, R.S., Bacon, B.R., Roopenian, D.C. & Sly, W.S. (2001) Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proceedings of the National Academy of Sciences of the United States of America, 98, 2707-2711.
10. Garby, L. & Noyes, W.D. (1959) Studies on hemoglobin metabolism. 1. The kinetic properties of the plasma hemoglobin pool in normal man. Journal of Clinical Investigation, 38, 1479-1483.
11. Guttridge, M.G., Thompson, J., Worwood, M. & Darke, C. (1998) Rapid detection of genetic mutations associated with haemochromatosis. Vox Sanguinis, 75, 253-256.
12. Hudson, B.L., Sunderland, E., Cartwright, R.A., Benson, E.A., Smiddy, F.G. & Cartwright, S.C. (1982) Haptoglobin phenotypes in 2 series of breast cancer patients. Human Heredity, 32, 219-221.
13. Jackson, H.A., Bowen, D.J. & Worwood, M. (1997) Rapid genetic screening for haemochromatosis using heteroduplex technology. British Journal of Haematology, 98, 856-859.
14. Jackson, H.A., Carter, K., Darke, C., Guttridge, M.G., Ravine, D., Hutton, R.D., Napier, J.A. & Worwood, M. (2001) HFE mutations, iron deficiency and overload in 10 500 blood donors. British Journal of Haematology, 114, 474-484.
15. Kasvosve, I., Gordeuk, V.R., Delanghe, J.R., Gomo, Z.A., Gangaidzo, I.T., Khumalo, H., Moyo, V.M., Saungweme, T., Mvundura, E. & Boelaert, J.R. (2002) Iron status in black persons is not influenced by haptoglobin polymorphism. Clinical Chemistry and Laboratory Medicine, 40, 810-813.
16. Koch, W., Latz, W., Eichinger, M., Roguin, A., Levy, A.P., Schömig, A. & Kastrati, A. (2002) Genotyping of the common haptoglobin Hp1/2 polymorphism based on PCR. Clinical Chemistry, 48, 1377-1382.
17. Koda, Y., Soejima, M., Yoshioka, N. & Kimura, H. (1998) The haptoglobin-gene deletion responsible for anhaptoglobinemia. American Journal of Human Genetics, 62, 245-252.
18. Kristiansen, M., Graversen, J.H., Jacobsen, C., Sonne, O., Hoffman, H.J., Law, S.K.A. & Moestrup, S.K. (2001) Identification of the haemoglobin scavenger receptor. Nature, 409, 198-201.
19. Langlois, M.R. & Delanghe, J.R. (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clinical Chemistry, 42, 1589-1600.
20. Langlois, M.R., Delanghe, J.R., DeBuyzere, M.L., Bernard, D.R. & Ouyang, J. (1997) Effect of haptoglobin on the metabolism of vitamin C. American Journal of Clinical Nutrition, 66, 606-610.
21. Langlois, M.R., Martin, M.E., Boelaert, J.R., Beaumont, C., Taes, Y.E., De Buyzere, D.R., Neels, H.M. & Delanghe, J.R. (2000) The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clinical Chemistry, 46, 1619-1625.
22. Levy, A.P., Roguin, A., Hochberg, I., Herer, P., Marsh, S., Nakhoul, F.M. & Skorecki, K. (2000) Haptoglobin phenotype and vascular complications in patients with diabetes. New England Journal of Medicine, 343, 969-970.
23. Levy, J.E., Montross, L.K. & Andrews, N.C. (2000) Genes that modify the hemochromatosis phenotype in mice. Journal of Clinical Investigation, 105, 1209-1216.
24. Lim, S.K., Kim, H., Lim, S.K., Ali, A.B., Lim, Y.K., Wang, Y., Chong, S.M., Constantini, F. & Baumman, H. (1998) Increased susceptibility in Hp knockout mice during acute hemolysis. Blood, 92, 1870-1877.
25. McCune, C.A., Al-Jader, L.N., May, A., Hayes, S.L., Jackson, H.A. & Worwood, M. (2002) Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Human Genetics, 111, 538-543.
26. Mastana, S.S. & Fisher, P. (1994) Haptoglobin subtypes in the East Midlands (United Kingdom). International Journal of Legal Medicine, 107, 52-54.
27. Nakhoul, F.M., Zoabi, R., Kanter, Y., Zoabi, M., Skorecki, K., Hochberg, I., Leibu, R., Miller, B.P. & Levy, A.P. (2001) Haptoglobin phenotype and diabetic nephropathy. Diabetologia, 44, 602-604.
28. Niederau, C., Fischer, R., Purschel, A., Stremmel, W., Haussinger, D. & Strohmeyer, G. (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology, 110, 1107-1119.
29. Phatak, P.D., Ryan, D.H., Cappuccio, J., Oakes, D., Braggins, C., Provenzano, K., Eberly, S. & Sham, R.L. (2002) Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells, Molecules and Diseases, 29, 41-47.
30. Roy, C.N. & Andrews, N.C. (2001) Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. Human Molecular Genetics, 10, 2181-2186.
31. The UK Haemochromatosis Consortium (1997) A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut, 41, 841-844.
32. Townsend, A. & Drakesmith, H. (2002) Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload. Lancet, 359, 786-790.
33. Van Vlierberghe, H., Langlois, M.R., Delanghe, J.R., Horsmans, Y., Michielsen, P., Henrion, J., Cartuyvels, R., Billiet, J., De Vos, M. & Leroux-Roels, G. (2001) Haptoglobin phenotype 2-2 over-representation in Cys282Tyr hemochromatotic patients. Journal of Hepatology, 35, 707-711.
34. Whitfield, J.B., Cullen, L.M., Jazwinska, E.C., Powell, L.W., Heath, A.C., Zhu, G., Duffy, D.L. & Martin, N.G. (2000) Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. American Journal of Human Genetics, 66, 1246-1258.
35. Worwood, M., Jackson, H.A., Feeney, G.P., Edwards, C. & Bowen, D.J. (1999) A single tube heteroduplex PCR for the common HFE genotypes. Blood, 94, 405a.
36. Zhao, H. & Zhang, G. (1993) Haptoglobin groups and cirrhosis of the liver. Human Heredity, 43, 134-136.
37. Zipprich, B., Giebelmann, R., Tolani, K., Schmidt, W., Konigstedt, B., Scheibe, E. & Nilius, R. (1986) Haptoglobin type and liver disease. Hepatogastroenterology, 33, 196-198.